Verastem, Inc. (VSTM)

6.375 -0.32 (-4.71%) USD  |  NASDAQ  |  Jan 23, 16:00
6.375 0.00 (0.00%) After-Hours: 16:13
More

Verastem CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for VSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
Anavex Life Sciences Corp. --
ADMA Biologics, Inc. Upgrade
Ocugen, Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade